Subtopic Deep Dive
Stem Cell Therapy Osteonecrosis
Research Guide
What is Stem Cell Therapy Osteonecrosis?
Stem cell therapy for osteonecrosis applies mesenchymal stem cells via decompression or injection to regenerate bone marrow and halt femoral head collapse in avascular necrosis.
Mesenchymal stem cells from bone marrow or induced pluripotent sources promote angiogenesis and osteogenesis in osteonecrosis of the femoral head (ONFH). Hernigou et al. (2005) demonstrated percutaneous autologous bone marrow transplantation efficacy in avascular necrosis (301 citations). Over 20 papers explore cell delivery and outcomes versus core decompression alone.
Why It Matters
Stem cell therapy targets early-stage ONFH, potentially delaying total hip arthroplasty in 20,000-30,000 annual US cases (Moya-Angeler et al., 2015). Hernigou et al. (2005) showed 70% success in pain relief and bone repair. Liu et al. (2017) reported iPSC-MSC exosomes preventing collapse via angiogenesis in rat models, offering non-surgical options for young patients (average age 33-38; Petek et al., 2019).
Key Research Challenges
Cell Source Variability
Differences in mesenchymal stem cell potency from bone marrow versus iPSCs affect regeneration consistency (Liu et al., 2017). Hernigou et al. (2005) used autologous marrow but noted donor-site morbidity. Optimization requires comparing sources in trials.
Angiogenesis Promotion
Restoring femoral head blood supply remains critical, as ischemia drives collapse (Marenzana and Arnett, 2013). Tao et al. (2017) showed platelet exosomes activating Akt/Bad/Bcl-2 against GC-induced apoptosis. Sustained vascular integration post-implantation challenges persist.
Long-term Collapse Prevention
Early gains fade without biomechanical support in trabecular bone (Oftadeh et al., 2014). Petek et al. (2019) highlight need for level 1 evidence on progression to arthroplasty. Trials lack standardized outcomes beyond 5 years.
Essential Papers
Current concepts on osteonecrosis of the femoral head
Joaquín Moya-Angeler · 2015 · World Journal of Orthopedics · 508 citations
It is estimated that 20000 to 30000 new patients are diagnosed with osteonecrosis annually accounting for approximately 10% of the 250000 total hip arthroplasties done annually in the United States...
Biomechanics and Mechanobiology of Trabecular Bone: A Review
Ramin Oftadeh, Miguel Perez‐Viloria, Juan C. Villa‐Camacho et al. · 2014 · Journal of Biomechanical Engineering · 485 citations
Trabecular bone is a highly porous, heterogeneous, and anisotropic material which can be found at the epiphyses of long bones and in the vertebral bodies. Studying the mechanical properties of trab...
Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment
Daniel Petek, Didier Hannouche, Domizio Suvà · 2019 · EFORT Open Reviews · 369 citations
Osteonecrosis of the femoral head is a disabling pathology affecting a young population (average age at treatment, 33 to 38 years) and is the most important cause of total hip arthroplasty in this ...
The Key Role of the Blood Supply to Bone
Massimo Marenzana, Timothy R. Arnett · 2013 · Bone Research · 355 citations
Exosomes derived from human platelet-rich plasma prevent apoptosis induced by glucocorticoid-associated endoplasmic reticulum stress in rat osteonecrosis of the femoral head via the Akt/Bad/Bcl-2 signal pathway
Shi‐Cong Tao, Ting Yuan, Biyu Rui et al. · 2017 · Theranostics · 343 citations
An excess of glucocorticoids (GCs) is reported to be one of the most common causes of osteonecrosis of the femoral head (ONFH). In addition, GCs can induce bone cell apoptosis through modulating en...
The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone
Philippe Hernigou, Alexandre Poignard, O. Manicom et al. · 2005 · Journal of Bone and Joint Surgery - British Volume · 301 citations
The Journal of Bone and Joint Surgery. British volumeVol. 87-B, No. 7 Aspects of Current ManagementFree AccessThe use of percutaneous autologous bone marrow transplantation in nonunion and avascula...
Pathophysiology and risk factors for osteonecrosis
Kalpit N. Shah, Jennifer Racine, Lynne C. Jones et al. · 2015 · Current Reviews in Musculoskeletal Medicine · 295 citations
Reading Guide
Foundational Papers
Start with Hernigou et al. (2005) for core decompression + autologous MSCs (301 citations), then Marenzana and Arnett (2013) on bone blood supply (355 citations), Oftadeh et al. (2014) on trabecular biomechanics (485 citations).
Recent Advances
Petek et al. (2019) synthesizes treatment concepts (369 citations); Tao et al. (2017) on platelet exosomes (343 citations); Liu et al. (2017) on iPSC-MSC exosomes (247 citations).
Core Methods
Percutaneous bone marrow aspiration/concentration (Hernigou et al., 2005); exosome isolation from MSCs/iPSCs (Tao et al., 2017; Liu et al., 2017); core decompression with cell injection.
How PapersFlow Helps You Research Stem Cell Therapy Osteonecrosis
Discover & Search
Research Agent uses searchPapers('stem cell therapy osteonecrosis femoral head') to retrieve Hernigou et al. (2005), then citationGraph reveals 300+ downstream trials on MSC implantation; exaSearch uncovers unpublished protocols, while findSimilarPapers links to Liu et al. (2017) exosomes.
Analyze & Verify
Analysis Agent applies readPaperContent on Hernigou et al. (2005) to extract success rates, verifyResponse with CoVe cross-checks claims against Petek et al. (2019), and runPythonAnalysis plots survival curves from trial data using pandas for statistical verification; GRADE grading scores evidence as moderate for early ONFH stages.
Synthesize & Write
Synthesis Agent detects gaps like long-term iPSC-MSC data via contradiction flagging between Hernigou (2005) and Liu (2017), then Writing Agent uses latexEditText for manuscript drafting, latexSyncCitations integrates 50+ refs, and latexCompile generates review PDFs with exportMermaid for angiogenesis pathway diagrams.
Use Cases
"Analyze survival rates in Hernigou 2005 stem cell trials vs controls"
Research Agent → searchPapers → Analysis Agent → readPaperContent + runPythonAnalysis (pandas survival plots, Kaplan-Meier stats) → GRADE report with p-values and confidence intervals.
"Draft LaTeX review on MSC exosomes for ONFH"
Synthesis Agent → gap detection → Writing Agent → latexEditText (intro/methods) → latexSyncCitations (Tao 2017, Liu 2017) → latexCompile → PDF with figures.
"Find code for ONFH angiogenesis simulations"
Research Agent → paperExtractUrls (Oftadeh 2014) → paperFindGithubRepo → Code Discovery → githubRepoInspect (trabecular biomechanics FEM models) → runPythonAnalysis sandbox test.
Automated Workflows
Deep Research workflow scans 50+ ONFH papers via searchPapers → citationGraph → structured report ranking Hernigou (2005) efficacy; DeepScan applies 7-step CoVe to Tao et al. (2017) exosomes, verifying Akt pathway claims; Theorizer generates hypotheses on MSC-exosome combos from Liu (2017) and Petek (2019).
Frequently Asked Questions
What defines stem cell therapy for osteonecrosis?
Implantation of mesenchymal stem cells with decompression regenerates marrow and prevents femoral head collapse (Hernigou et al., 2005).
What methods improve outcomes?
Percutaneous autologous bone marrow concentrate yields 70% success; exosomes from iPSCs-MSCs promote angiogenesis (Liu et al., 2017; Hernigou et al., 2005).
What are key papers?
Hernigou et al. (2005, 301 citations) on autologous transplantation; Liu et al. (2017, 247 citations) on exosomes; Moya-Angeler et al. (2015, 508 citations) on ONFH epidemiology.
What open problems exist?
Lack of level 1 trials, long-term collapse data, and standardized cell dosing (Petek et al., 2019; Oftadeh et al., 2014).
Research Bone and Joint Diseases with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Stem Cell Therapy Osteonecrosis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Bone and Joint Diseases Research Guide